The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A protocol for systematic review and meta-analysis

BACKGROUND: Glucokinase activators are a novel family of glucose-lowering agents used for the treatment of type-2 diabetes mellitus (T2DM). Glucokinase activators blind to GK activate the enzyme allosterically. Treatment with different GKAs has been shown to reduce fasting and postprandial glucose i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899907/
https://www.ncbi.nlm.nih.gov/pubmed/33607862
http://dx.doi.org/10.1097/MD.0000000000024873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899907/
https://www.ncbi.nlm.nih.gov/pubmed/33607862
http://dx.doi.org/10.1097/MD.0000000000024873

Ejemplares similares